Cannabis is listed on the stock exchange!
Due to current media attention within the medical cannabis field, you may be familiar with some of the companies we host.
GW Pharmaceuticals (GWP.L) & (GWPRF.PK) in England is licensed by the UK Home Office to investigate and experiment with many controlled substances. They are responsible for developing Sativex ® Oromucosal Spray and developing the Advanced Dispensing System (ADS). As the UK and Canada share similar viewpoints regarding the benefits of medicinal cannabis, it is not uncommon for these groups to work in conjunction with each other. Sativex® is now prescribed in Canada.
Synthetic cannabis-related drugs are more widely prescribed in North America, especially Marinol ®, which is based on the cannabinoid structure of cannabis plants. The drug is produced by Solvay Pharmaceuticals Inc. (EBR:SVYSY) Solvay has also become famous for manufacturing peroxygens and plastics, although they are also responsible for supplying Nektar Therapeutics with a synthetic cannabinoid used for producing their own pharmaceuticals.
Nektar Therapeutics (NASDAQ:NKTR) is a biopharmaceutical company that focuses on patient analysis and quality of life when creating new drugs and technologies. In fact the space-age inhalers which have helped to make Nektar famous are the very ones used by Solvay for dispensation of their Dronabinol which is the active ingredient used in Marinol®.
Naturally the Netherlands is represented, as Omega Pharma NV (a/k/a Laboratoire Delta Pharm) (OMEP.BR) allows you to invest in the dispensation of Dutch medical cannabis.
Finally, space has been designated for a major staple of the hemp industry: clothing and textiles. Naturally Advanced (TSX-V) & (NADVF) has been specializing in eco- business, promotional, and private label clothing since 1993, and have experiences major success with their breakthrough fabric Crailar®.
Find out more within our pages, and happy investing!May 01, 2010